- Accession Number
Compounds with a 10-carbon ring.
Drug Drug Description Paclitaxel A taxoid chemotherapeutic agent used as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary, and other various cancers including breast and lung cancer. Docetaxel A taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer. Paclitaxel docosahexaenoic acid Investigated for use/treatment in breast cancer, colorectal cancer, gastric cancer, kidney cancer, lung cancer, pancreatic cancer, prostate cancer, and skin cancer. AI-850 Investigated for use/treatment in breast cancer and solid tumors. Paclitaxel trevatide Investigated for use/treatment in brain cancer. Cabazitaxel An antineoplastic agent used for the treatment of hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing treatment regimen. Ortataxel Ortataxel has been used in trials studying the treatment of Lymphoma, Lung Cancer, Glioblastoma, and Kidney Cancer. Tesetaxel Tesetaxel has been used in trials studying the treatment of Cancer, Melanoma, Prostate Cancer, Gastric Carcinoma, and Advanced Melanoma, among others. Milataxel Milataxel has been used in trials studying the treatment of Mesothelioma. BMS-188797 BMS-188797 has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific. BMS-184476 BMS-184476 has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific. Larotaxel Larotaxel has been used in trials studying the treatment of Cancer, Metastases, Breast Cancer, Breast Neoplasms, and Pancreatic Neoplasms, among others. Paclitaxel poliglumex Not Annotated Simotaxel Simotaxel is under investigation in clinical trial NCT00088647 (Study Evaluating MST-997 in Advanced Malignant Solid Tumors).
- Drugs & Drug Targets